Literature DB >> 8153659

Neuropathology of malignant gliomas.

J M Bruner1.   

Abstract

Astrocytomas are the most common primary gliomas, with the highly anaplastic glioblastoma multiforme being the most frequently occurring astrocytoma. Distinctive histological features permit astrocytomas to be graded into levels of anaplasia, and these histological grades correlate with biological behavior and patient prognosis. However, there is also a strong correlation between patient age, tumor grade, and prognosis. More objective indicators of tumor proliferative potential, such as BUdR or Ki-67 LI, are currently being investigated with the hope that these will be a more accurate means of predicting patient survival. Oligodendrogliomas are a much less common primary glioma, with a generally better survival rate than astrocytomas. However, grading systems for oligodendrogliomas are not well defined. For any type of glioma, subsequent surgery after radiation therapy may be required for treatment of therapeutic effects or for therapy planning at recurrence. The histological changes observed in these post-therapy biopsy specimens or resections may be difficult to distinguish from reactive changes that can simulate recurrent tumor and vice versa.

Entities:  

Mesh:

Year:  1994        PMID: 8153659

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


  11 in total

Review 1.  Extent of resection as a prognostic variable in the treatment of gliomas.

Authors:  K R Hess
Journal:  J Neurooncol       Date:  1999-05       Impact factor: 4.130

2.  Value of perfusion weighted magnetic resonance imaging in the diagnosis of supratentorial anaplastic astrocytoma.

Authors:  Kyung Mi Lee; Eui Jong Kim; Geon-Ho Jahng; Bong Jin Park
Journal:  J Korean Neurosurg Soc       Date:  2014-09-30

3.  Radiation change versus recurrent astrocytoma: diagnostic utility of the proliferation index?

Authors:  E H Bigio; S M Colvin; B E Mickey; C L White; E J Rushing
Journal:  J Neurooncol       Date:  1999-01       Impact factor: 4.130

Review 4.  PCV chemotherapy for oligodendroglioma: response analyzed on T2 weighted-MRI.

Authors:  S Diabira; M C Rousselet; E Gamelin; P Soulier; E Jadaud; P Menei
Journal:  J Neurooncol       Date:  2001-10       Impact factor: 4.130

5.  Analysis of EGFR gene amplification, protein over-expression and tyrosine kinase domain mutation in recurrent glioblastoma.

Authors:  Judit Toth; Kristof Egervari; Almos Klekner; Laszlo Bognar; Janos Szanto; Zoltan Nemes; Zoltan Szollosi
Journal:  Pathol Oncol Res       Date:  2008-08-28       Impact factor: 3.201

6.  A histopathological contribution to supratentorial glioma grading, definition of mixed gliomas and recognition of low grade glioma with Rosenthal fibers.

Authors:  J M Cillekens; J A Beliën; P van der Valk; T J Faes; P J van Diest; M A Broeckaert; J H Kralendonk; W Kamphorst
Journal:  J Neurooncol       Date:  2000       Impact factor: 4.130

7.  Prognostic value of loss of heterozygosity around three candidate tumor suppressor genes on chromosome 10q in astrocytomas.

Authors:  Kinya Terada; Takashi Tamiya; Shigeru Daido; Hirokazu Kambara; Hiroaki Tanaka; Yasuhiro Ono; Kengo Matsumoto; Sachio Ito; Mamoru Ouchida; Takashi Ohmoto; Kenji Shimizu
Journal:  J Neurooncol       Date:  2002-06       Impact factor: 4.130

Review 8.  The expanding role of chemotherapy for pediatric supratentorial malignant gliomas.

Authors:  D C Lyden; W P Mason; J L Finlay
Journal:  J Neurooncol       Date:  1996 May-Jun       Impact factor: 4.130

Review 9.  Current perspectives in gliomas.

Authors:  C S Brock; M Bower
Journal:  Med Oncol       Date:  1997-06       Impact factor: 3.738

10.  Mitotic count reflects prognosis of gallbladder cancer particularly among patients with T3 tumor.

Authors:  Keita Kai; Masanori Masuda; Takao Ide; Yukari Takase; Atsushi Miyoshi; Kenji Kitahara; Kohji Miyazaki; Hirokazu Noshiro; Osamu Tokunaga
Journal:  Mol Clin Oncol       Date:  2013-05-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.